InxMed
InxMed is a clinical-stage biotech company dedicated to developing innovative, individualized medicines with international impact.
InxMed is active in the biotechnology, life science space based in Asia-Pacific (APAC), founded in 2018.
The company sits in the biotechnology, life science segment, where it competes on its core product or service.
The business is associated with Asia-Pacific (APAC).
It is recorded at the Debt_Financing stage.
Its team size is recorded as c_00011_00050 employees.
Total disclosed funding stands at about $94M.
| Sector | Biotechnology, Life Science |
|---|---|
| Headquarters | Asia-Pacific (APAC) |
| Founded | 2018 |
| Employees | c_00011_00050 |
| Stage | debt_financing |
| Total funding | $93,998,904 |
Website: en.inxmed.com
Emails and contact routes are reserved for registered members.
Create a free account
Create a free account